Shares of cancer-treatment company ArQule surge 100 percent on Merck acquisitionNew York Post • 12/09/19
Merck Stock Is On An Upswing In 2019 — Should You Buy This Pharma Stock?Investors Business Daily • 12/05/19
Merck Isn't Too Reliant on Keytruda Yet, and That's Good News for InvestorsThe Motley Fool • 12/03/19
Dow Jones Stocks Merck, Intel, American Express, Coca-Cola, Nike Are Near Buy PointsInvestors Business Daily • 12/01/19